Skip to content

The association of mindfulness and depression stigma among African American women participants in a mindfulness-based intervention: A pilot study.

Sunghyun Hong, Maureen D Satyshur, Inger Burnett-Zeigler

Transcultural Psychiatry May 3, 2022 DOI: 10.1177/13634615221076709 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pilot study Qualitative Peer reviewed
Sample size 31
Population African American women with depressive symptoms recruited from an urban Federally Qualified Health Center (FQHC)
Duration Eight-week intervention with assessments at baseline, eight weeks, and 16 weeks
Topics Depression Meditation
Keywords Humans Focus groups Pilot projects Female African american women Depression stigma
Key points Mindfulness increased significantly from baseline to eight weeks, and depression decreased significantly from baseline to 16 weeks but not by eight weeks. Depression stigma increased significantly from baseline to eight weeks and then decreased significantly from eight to 16 weeks, without returning to baseline. Focus group themes pointed to direct and indirect factors that may perpetuate and maintain depression stigma.

Abstract

Depression stigma is a potential barrier to engagement in and efficacy of depression treatment. This pilot study examined the association of mindfulness with depression stigma among participants in an eight-week mindfulness-based intervention for depressive symptoms. Thirty-one African American women with depressive symptoms were recruited from an urban Federally Qualified Health Center (FQHC) to participate in a mindfulness intervention (M-Body). Mindfulness, depressive symptoms, and depression stigma were assessed at baseline, eight weeks, and 16 weeks. Focus groups were conducted to examine participants' subjective experiences with the mindfulness intervention. Mindfulness significantly increased from baseline to eight weeks. There was a non-significant decrease in depression from baseline to eight weeks and a significant decrease in depression from baseline to 16 weeks. Depression stigma significantly increased from baseline to eight weeks and significantly decreased from eight to 16 weeks; however, depression stigma did not return to the baseline. An exploratory qualitative analysis of focus group data revealed themes related to direct and indirect factors that may perpetuate and maintain depression stigma. This is one of the first studies to explicitly explore the relationship between mindfulness, depression symptoms, and depression stigma among African American women.

Comparable studies

Other non-randomized and open-label trials on depression, most cited first.

Study Year Design Participants
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Patients with moderate-to-severe, unipolar, treatment-resistant major depression 2016 Open-label feasibility trial n = 12
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Patients with severe, unipolar, treatment-resistant major depression 2017 Open-label trial n = 20
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression Patients with recurrent depression 2015 Open-label trial n = 17

Citations in the library

Explore topics